Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuomas Selander

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
Cancer Genomics & Proteomics|April 24, 2016
Does Post-Surgery Placement of Rectus Sheath Block Analgesia Alter the Oxidative Stress Biomarker 8-OHdG Concentrations: A Randomised Trial of Patients with Cancer and Benign DiseaseMartin Purdy, Merja Kokki, Maarit Anttila, et al.
Anticancer Research|June 9, 2016
Does the Rectus Sheath Block Analgesia Reduce the Inflammatory Response Biomarkers' IL-1ra, IL-6, IL-8, IL-10 and IL-1β Concentrations Following Surgery? A Randomized Clinical Trial of Patients with Cancer and Benign DiseaseMartin Purdy, Merja Kokki, Maarit Anttila, et al.
European Journal of Public Health|May 15, 2018
Manual handling of burdens as a predictor of birth outcome-a Finnish Birth Register StudyEmma Kwegyir-Afful, Reeta Lamminpää, Tuomas Selander, et al.
Critical Care (London, England)|April 19, 2015
Predicting one-year mortality of critically ill patients with early acute kidney injury: data from the prospective multicenter FINNAKI studyMeri Poukkanen, Suvi T Vaara, Matti Reinikainen, et al.
Acta Anaesthesiologica Scandinavica|April 10, 2020
Noninterventional follow-up vs fluid bolus in RESPONSE to oliguria-The RESPONSE trial protocol and statistical analysis planNina Inkinen, Tuomas Selander, Ville Pettilä, et al.
Brain and Behavior|June 29, 2022
Grey matter atrophy in patients with benign multiple sclerosisMarja Niiranen, Juha Koikkalainen, Jyrki Lötjönen, et al.
Journal of Clinical Epidemiology|November 25, 2021
Mortality prediction in intensive care units including premorbid functional status improved performance and internal validityAndré Moser, Matti Reinikainen, Stephan M Jakob, et al.
Multiple Sclerosis and Related Disorders|June 24, 2020
Corrigendum to "Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation" [Multiple Sclerosis and Related Disorders 38 (2020) 101498]Tiina Mustonen, Ilkka Rauma, Päivi Hartikainen, et al.
BMC Cancer|December 4, 2023
A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitorsSatu Tiainen, Veera Nurmela, Tuomas Selander, et al.
BMC Cancer|March 4, 2022
Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysisInka Puhakka, Hanne Kuitunen, Pekka Jäkälä, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
Cancer Genomics & Proteomics|April 24, 2016
Does Post-Surgery Placement of Rectus Sheath Block Analgesia Alter the Oxidative Stress Biomarker 8-OHdG Concentrations: A Randomised Trial of Patients with Cancer and Benign DiseaseMartin Purdy, Merja Kokki, Maarit Anttila, et al.
Anticancer Research|June 9, 2016
Does the Rectus Sheath Block Analgesia Reduce the Inflammatory Response Biomarkers' IL-1ra, IL-6, IL-8, IL-10 and IL-1β Concentrations Following Surgery? A Randomized Clinical Trial of Patients with Cancer and Benign DiseaseMartin Purdy, Merja Kokki, Maarit Anttila, et al.
European Journal of Public Health|May 15, 2018
Manual handling of burdens as a predictor of birth outcome-a Finnish Birth Register StudyEmma Kwegyir-Afful, Reeta Lamminpää, Tuomas Selander, et al.
Critical Care (London, England)|April 19, 2015
Predicting one-year mortality of critically ill patients with early acute kidney injury: data from the prospective multicenter FINNAKI studyMeri Poukkanen, Suvi T Vaara, Matti Reinikainen, et al.
Acta Anaesthesiologica Scandinavica|April 10, 2020
Noninterventional follow-up vs fluid bolus in RESPONSE to oliguria-The RESPONSE trial protocol and statistical analysis planNina Inkinen, Tuomas Selander, Ville Pettilä, et al.
Brain and Behavior|June 29, 2022
Grey matter atrophy in patients with benign multiple sclerosisMarja Niiranen, Juha Koikkalainen, Jyrki Lötjönen, et al.
Journal of Clinical Epidemiology|November 25, 2021
Mortality prediction in intensive care units including premorbid functional status improved performance and internal validityAndré Moser, Matti Reinikainen, Stephan M Jakob, et al.
Multiple Sclerosis and Related Disorders|June 24, 2020
Corrigendum to "Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation" [Multiple Sclerosis and Related Disorders 38 (2020) 101498]Tiina Mustonen, Ilkka Rauma, Päivi Hartikainen, et al.
BMC Cancer|December 4, 2023
A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitorsSatu Tiainen, Veera Nurmela, Tuomas Selander, et al.
BMC Cancer|March 4, 2022
Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysisInka Puhakka, Hanne Kuitunen, Pekka Jäkälä, et al.
Pageof 15